Press releases
- MindMed to Present at Upcoming April Medical Conferences
- MindMed Announces Voluntary Delisting from Cboe Canada
- MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
- Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
- MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
- MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
- MindMed Reports 2023 Financial Results and Business Updates
- MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
- MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference
More ▼
Key statistics
On Friday, Mind Medicine (MindMed) Inc (MMQ:FRA) closed at 8.14, -32.38% below its 52-week high of 12.03, set on Apr 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.36 |
---|---|
High | 8.37 |
Low | 8.14 |
Bid | -- |
Offer | -- |
Previous close | 8.38 |
Average volume | 4.43k |
---|---|
Shares outstanding | 70.27m |
Free float | 68.57m |
P/E (TTM) | -- |
Market cap | 609.93m USD |
EPS (TTM) | -2.45 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 14:32 BST.
More ▼